Medications - Page 4

April 3, 2026

Breakthrough ALS study launches as drug aims to slow disease progression

The PREVAiLS study, believed to be the only recruiting phase 3 ALS trial, aims to slow disease progression and preserve function in early-stage patients.

April 2, 2026

New weight-loss pill hits the market, promising 'greater flexibility'

FDA approves Foundayo, a once-daily weight loss pill by Lilly. Clinical trials showed adults lost an average of 27.3 pounds on the highest dose, although there are side effects.

April 1, 2026

Should you microdose Ozempic? Experts are split on risks vs benefits

Microdosing GLP-1 drugs is trending on social media and supported by some doctors, but experts warn the practice lacks a standard protocol and may undermine weight-loss results.

March 31, 2026

Aggressive brain cancer may respond to high-dose vitamin therapy, study suggests

High-dose vitamin B3 (niacin) may boost immune function and slow glioblastoma progression, with 82% of trial patients showing no disease progression after six months.

March 31, 2026

Healing after a heart attack: New injection could help reverse damage

Columbia University scientists developed a two-step RNA therapy that may repair cardiovascular tissue after a heart attack by turning muscles into a "healing protein factory."

March 31, 2026

Common blood pressure pill could make certain cancer treatments more powerful

Telmisartan, an FDA-approved blood pressure drug, could boost a certain cancer treatment's effectiveness against tumors, a new Dartmouth study finds.

March 29, 2026

Cases of 'white plague' rising in US as doctors warn of 'rebound effect'

Tuberculosis, also known as "the white plague," is rising in the U.S. post-pandemic, with over 10,600 cases confirmed in 2024, the CDC reports.

March 28, 2026

Hormone therapy boosts weight loss drug results by 35% in women, study finds

A Mayo Clinic study suggests postmenopausal women lost 35% more weight combining hormone therapy with tirzepatide, though experts urge caution on the findings.

March 24, 2026

New stronger weight-loss drug gets green light from FDA: 'Major jump'

The FDA approved Wegovy HD, a higher-dose semaglutide for weight loss in adults with obesity, offering greater weight reduction, as experts warn of side effects.

March 24, 2026

Stopping GLP-1 drugs like Ozempic erodes heart health benefits quickly, new study finds

Stopping GLP-1 drugs like Ozempic quickly erodes heart protection, with two years off the medication raising cardiovascular risk by 22%, a new study finds.